NEW YORK, Nov. 7 — San Diego-based GeneFormatics on Wednesday said that it has added Edward Lanphier to its board of directors.

Lanphier, the founder, president and CEO of Sangamo BioSciences, will assist the privately-held structural proteomics firm with business development and management. 

Lanphier founded Sangamo BioSciences in 1997. Before that he was a senior executive at Somatix Therapy Corporation, vice president for corporate development at Synergen, and the former president and CEO of BioGrowth.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Magdalena Skipper, the incoming editor-in-chief of Nature, speaks with NPR's Weekend Edition Sunday.

Genetic genealogy has led to an arrest in another cold case, dating back to 1987.

Wired reports that 23andMe is trying to bolster its outside collaborations.

In PLOS this week: mutation in second gene widens clinical symptoms of people with ADD3 mutations, comparative genomic analysis of Pseudovibrio, and more.